Varex Imaging Corp (VREX)

Currency in USD
10.92
+0.20(+1.87%)
Closed·
10.920.00(0.00%)
·
Earnings results expected in 9 days
VREX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
10.6411.07
52 wk Range
6.7614.57
Key Statistics
Prev. Close
10.72
Open
10.79
Day's Range
10.64-11.07
52 wk Range
6.76-14.57
Volume
475.68K
Average Volume (3m)
457.66K
1-Year Change
39.1083%
Book Value / Share
11.31
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VREX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
18.00
Upside
+64.84%
Members' Sentiments
Bearish
Bullish
ProTips
2 analysts have revised their earnings downwards for the upcoming period

Varex Imaging Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Analyst Ratings

4 Buy
1 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 18.00
(+64.84% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
B.Riley
Buy18.00+64.84%16.00MaintainFeb 12, 2026
Jefferies
Hold14.50+32.78%12.00MaintainFeb 02, 2026
Oppenheimer
Buy18.00+64.84%23.00MaintainNov 19, 2025
Jefferies
Hold12.00+9.89%10.00MaintainOct 03, 2025
B.Riley
Buy16.00+46.52%12.00MaintainAug 08, 2025

Varex Imaging Corp Earnings Call Summary for Q2/2026

  • Varex Imaging Q2 FY2026 EPS of $0.21 beat forecast by 5%; revenue rose 1% YoY to $216M, exceeding expectations of $214.57M.
  • Gross margin declined 240 bps YoY to 34% due to rising input costs; stock fell 2.79% to $11.99 despite earnings beat.
  • Medical segment grew 2%, industrial up 1%; EMEA region declined 16% presenting geographic challenges for the company.
  • Company investing in AI-enabled imaging and photon counting technology to drive future growth and expand market opportunities.
  • Q3 FY2026 EPS guidance of $0.23, Q4 at $0.30; analysts predict profitability this year with net income expected to grow.
Last Updated: 2026-05-07, 10:30 p/m
Read Full Transcript

Earnings

Latest Release
May 07, 2026
EPS / Forecast
0.21 / 0.20
Revenue / Forecast
216M / 214.57M
EPS Revisions
Last 90 days

VREX Income Statement

Compare VREX to Peers and Sector

Metrics to compare
VREX
Peers
Sector
Relationship
P/E Ratio
−5.6x12.5x−0.3x
PEG Ratio
0.06−0.040.00
Price/Book
1.0x2.8x2.6x
Price / LTM Sales
0.5x2.1x2.9x
Upside (Analyst Target)
64.8%62.3%57.8%
Fair Value Upside
Unlock15.7%9.5%Unlock

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. It sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, Latin America, Europe, the Middle East, India, Africa, Asia, and Australia. The company was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
18.11M42.97%197.77M
Other Institutional Investors
24.33M57.03%265.73M
Public Companies & Retail Investors
0.000.00%0.00
Total
42.44M100.00%463.5M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Pzena Investment Management, Inc.9.47%3,992,28043,596
BlackRock, Inc.9.06%3,817,83041,691

People Also Watch

13.710
MAGN
+3.39%
26.02
DLX
+1.76%
29.34
PUK
+0.86%
238.92
RGA
+1.98%
80.82
SF
+1.58%

FAQ

What Is the Varex Imaging (VREX) Stock Price Today?

The Varex Imaging stock price today is 10.92 USD.

What Stock Exchange Does Varex Imaging Trade On?

Varex Imaging is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Varex Imaging?

The stock symbol for Varex Imaging is "VREX."

What Is the Varex Imaging Market Cap?

As of today, Varex Imaging market cap is 460.24M USD.

What Is Varex Imaging's Earnings Per Share (TTM)?

The Varex Imaging EPS (TTM) is -1.99.

When Is the Next Varex Imaging Earnings Date?

Varex Imaging will release its next earnings report on Aug 04, 2026.

From a Technical Analysis Perspective, Is VREX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Varex Imaging Stock Split?

Varex Imaging has split 0 times.

How Many Employees Does Varex Imaging Have?

Varex Imaging has 2450 employees.

What is the current trading status of Varex Imaging (VREX)?

As of Jul 26, 2026, Varex Imaging (VREX) is trading at a price of 10.92 USD, with a previous close of 10.72 USD. The stock has fluctuated within a day range of 10.64 USD to 11.07 USD, while its 52-week range spans from 6.76 USD to 14.57 USD.

What Is Varex Imaging (VREX) Price Target According to Analysts?

The average 12-month price target for Varex Imaging is 18.00 USD, with a high estimate of 22 USD and a low estimate of 12 USD. 4 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +64.84% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.